PT Famon Awal Bros Sedaya Tbk

pray

Overview

PRAY Overview

PT Famon Awal Bros Sedaya Tbk is an Indonesia-based holding company. The Company is engaged in private hospital activities and other management consulting. The Company operates approximately 15 hospitals across various cities in Indonesia. Its geographical segments include Jawa, Kalimantan dan and Sulawesi, and Sumatera. The Company’s subsidiaries include PT Famon Global Medika, PT Fortuna Anugerah Sehat, PT Fortuna Anugerah Medika, PT Fortuna Graha Sentosa, PT Fortuna Medika Sejahtera, PT Fortuna Prima Sentosa, PT Fortuna Sentosa Sejahtera, PT Fortuna Griya Medika, PT Fortuna Selamat Sejahtera, PT Global Prime System and PT Kasih Karunia Alkesindo, and others.

24681012ValueCompetitiveFutureFinancialsDividend
Exchange
Indonesia Stock Exchange

Symbol: PRAY

Development
Market Cap.
IDR 9.42Trillion

~$599.68M USD

Industry
Healthcare Providers
Sub-Industry
Healthcare Providers
Sector
Healthcare

Valuation

PRAY Valuation Metrics

675

IDR

Closing Price on 2024-04-05

Price to Equity

53.64

P/E

At 53.64x P/E TTM, PRAY.JK is trading at a premium to its peers in the Healthcare Equipment & Providers sector (avg 23.8x).

Price to Book

3.42

P/B

At 3.42x P/B TTM, PRAY.JK is trading at a premium to its peers in the Healthcare Equipment & Providers sector (avg 1.8x).

Price to Sales

5.54

P/S

At 5.54x P/S TTM, PRAY.JK is trading at a premium to its peers in the Healthcare Equipment & Providers sector (avg 3.0x).

Valuing PT Famon Awal Bros Sedaya Tbk based on its trailing twelve months (TTM) valuation metrics against its peers in the Healthcare Equipment & Providers sector

Historical Price to Earnings

Other Valuation Metrics

Valuing PT Famon Awal Bros Sedaya Tbk relative to other stocks in the Healthcare Equipment & Providers sector

Price/Cash Flow
-26.08x
Price/Forward Earnings
-
Enterprise Value/Revenue
5.52x
Enterprise Value/EBITDA
31.44x
PEG Ratio
-

Analyst Ratings

No analyst ratings available yet.

Last closing: IDR6752024-04-05
IDR 137.83

Considerably Lower Intrinsic Value: Analyst's intrinsic value is of PRAY is IDR138, which is 79% lower than PRAY's last closing price of IDR675 (as of 2024-04-05).

Valuation Recap of PRAY stock
WeightNotesScore
High
The P/E ratio is calculated by dividing the market price of a company's stock by its earnings per share (EPS). It is a key tool for investors and analysts to assess whether a stock is overvalued, undervalued, or fairly valued. A P/E ratio of 53.64x is above the ID market average of 8.22x and is trading at a premium to peers in the Healthcare Equipment & Providers sector (23.78x). In fact, less than 25% of its peers trade at a higher P/E ratio than PRAY.
Max 3
High
The P/B ratio is calculated by dividing the market price of a company's stock by its book value per share (BVPS). It measures the company's stock value relative to its assets minus liabilities. A P/B ratio of 3.42x is above the peers average of 1.80x in the Healthcare Equipment & Providers sector.
Max 3
Medium
The P/S ratio is calculated by dividing the market price of a company's stock by its sales per share. It measures the company's stock value relative to its sales. A P/S ratio of 5.54x is above the peers average of 3.00x in the Healthcare Equipment & Providers sector. When considered alongside the Forward Price/Earnings ratio, they serve to illustrate investors' expectations of PRAY's valuation relative to its current sales and future earnings growth.
Max 2
Low
The Price/Cash Flow ratio (P/CF) is calculated by dividing the market price of a company's stock by its cash flow per share. It measures the company's stock value relative to its cash flow, and is sometimes said to be a more objective measure of a company's value because cash flows cannot be manipulated as easily as earnings, which considers non-cash items such as depreciation and amortization. PRAY's P/CF ratio of -26.08x is considered healthy by analysts.●●
Max 2
Low
The Enterprise Value/Revenue ratio (EV/R) is calculated by dividing the enterprise value of a company by its revenue. It measures the company's enterprise value relative to its revenue. It is an indicator of how much it costs to buy the company's revenue; the lower the ratio, the cheaper the company's revenue. PRAY's EV/R ratio of 5.52x is considered a relatively high ratio The average EV/R ratio for the Healthcare Equipment & Providers sector is 2.98x.
Max 3
Medium
Considerably Lower Intrinsic Value: Analyst's intrinsic value is of PRAY is IDR 137.83, which is 79% lower than PRAY's last closing price of IDR 675.00.
Max 3

Peers

PRAY Peers and Comparison

Peer Companies

Supertype Fuzzy Search
SymbolCompany Name
Market Cap
(in Trillion IDR)
Total Assets
(in Trillion IDR)
Total Revenue
(in Trillion IDR)
Profit and Loss
(in Trillion IDR)
P/E
P/B
KLBFKalbe Farma Tbk68.46T27.18T 30.31T 2.96T 23.123.31
MIKAPT Mitra Keluarga Karyasehat Tbk.39.22T7.11T 4.13T 0.95T 41.297.01
SILOPT Siloam International Hospitals Tbk.32.40T10.75T 10.83T 1.11T 29.294.28
SRAJSejahteraraya Anugrahjaya Tbk20.58T5.62T 2.35T -0.05T -433.0911.10
SIDOPT Industri Jamu Dan Farmasi Sido Muncul Tbk20.25T3.75T 3.61T 0.97T 20.865.94
HEALPT Medikaloka Hermina Tbk.19.03T8.52T 5.54T 0.48T 39.485.15
PRAYPT Famon Awal Bros Sedaya Tbk9.42T4.42T 1.70T 0.18T 53.643.42
TSPCTempo Scan Pacific Tbk9.09T11.31T 12.93T 1.41T 6.431.18
SOHOPT Soho Global Health Tbk6.24T4.67T 7.91T 0.34T 18.422.45
OMEDPT Jayamas Medica Industri Tbk5.33T2.46T 1.63T 0.22T 23.782.50
Competitiveness Recap of PRAY stock
WeightNotesScore
High
At a market cap of IDR 9,422.60 billion, PRAY.JK ranks 7 in Market Cap out of 10 companies in the Healthcare sector.
Max 2
High
At a PE of 53.64, PRAY.JK ranks 1 out of 10 companies in the Healthcare sector for P/E value. The average PE is -17.68 (unadjusted). A high P/E ratio often indicates higher growth expectation, or other qualitative factors that led investors to believe that the company has a defensible competitive advantage compared to its peers in Healthcare. false●●
Max 2
Medium
At a PE of 53.64, PRAY.JK is trading at a higher PE than that of its subsector peers in Healthcare Equipment & Providers (median of 23.78). false●●
Max 2
Medium
At a revenue of IDR 1.70 trillion, PRAY.JK ranks 9 in Revenue out of 10 companies in the Healthcare sector.
Max 2
Medium
At a profit of IDR 0.18 trillion, PRAY.JK ranks 9 in Profit out of 10 companies in the Healthcare sector.
Max 2

Future

Future Growth of PRAY

Growth Forecasts

No data available

Sector Benchmark

Healthcare Equipment & Providers companies in Indonesia are growing at a projected rate of 23.68% against the IDX average of +12.0%.

Healthcare Equipment & Providers sector overview
No data is available for PRAY at the moment.
Future growth prospect of PRAY
WeightNotesScore
High
PRAY's projected growth rate of 23.68% is above the ID market average of 11.98%.●●●
Max 3
High
The Healthcare Equipment & Providers sub-sector is projected to grow revenue by 22.97% in 2024. This number is higher than the previous year 2023's growth rate of 9.96%. This bodes well for PRAY's revenue growth prospects in the next 2 years. ●●●
Max 3
Medium
The Healthcare Equipment & Providers sub-sector is projected to increase earnings by 29.75% in 2024. This number is higher than the previous year 2023's EPS growth of 9.77%. This bodes well for PRAY's earnings growth prospects in the next 2 years. ●●●
Max 3
Medium
PRAY and its peers in the Healthcare Equipment & Providers sub-sector belongs to the Healthcare sector. Companies in the Healthcare sector are projected to have a fruitful year heading into 2024. Specifically, earnings are projected to increase by 16.30% in 2024 while revenue growth is projected to increase by 17.10%. These macroeconomic trends will likely be a tailwind for PRAY's earnings growth prospects in the next 2 years. ●●
Max 3
Loading...
Loading...

Management

Executive Management

President Director

Arfan Awaloeddin15.2 years
Yoshen Danun
Director
Leona Agustine Karnali
Director
NamePositionShares%
Yos Effendi SusantoPresident Commissioner107,952,4000.77
Expressed in millions IDR, unless otherwise stated

Ownership

PRAY Ownership

Others
5.39%
Insiders
91.76%
Institutions
2.85%
NameNumber of SharesOwnership (%)Value
Pt Famon Obor Maju6,487,215,26746.474,378.87B
The Northern Trust Company S/A Archipelago Investment Pte Ltd3,789,358,40027.152,557.82B
Pt Awal Bros Citra Batam2,420,632,17617.341,633.93B
Public (Scripless)1,154,264,0578.27779.13B
Yos Effendi Susanto107,952,4000.7772.87B
No data is available for PRAY at the moment.